Skip to main content

Table 3 Comparison of AEs between sorafenib and RT

From: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

 

Sorafenib

RT

Grade 3/4 toxicity

  

Total (n)

19

1

AST/ALT increased

6

0

Anorexia/nausea

4

0

HFSR

3

0

Hepatic Failure

1

0

Ascites

1

0

Hypertension

1

0

Proteinuria

1

0

Sepsis

1

0

Thrombocytopenia

1

0

Anemia

0

0

Leukocytopenia

0

1

Pancreatitis

0

0

Discontinuation, n (%)

15 (54)

1 (4)

  1. Abbreviations: AEs adverse events, AST aspartate aminotransferase, ALT alanine aminotransferase, RT radiotherapy, HFSR hand-foot-skin reaction.